Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,752
Total Claims
$279K
Drug Cost
591
Beneficiaries
$473
Cost/Patient
Risk Score Breakdown 40/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1585%
Opioid rate vs peers
63.7% vs 3.8% avg
-60%
Cost per patient vs peers
$473 vs $1,174 avg
-66%
Brand preference vs peers
3.0% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 1,585% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
63.7%
Opioid Rate
4,304
Opioid Claims
$178K
Opioid Cost
10.4%
Long-Acting Rate
This provider's opioid prescribing rate of 63.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 204 claims · $90K
Generic: 6,548 claims · $189K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 1,364 | $41K |
| Oxycodone Hcl | 1,415 | $39K |
| Rimegepant Sulfate | 32 | $31K |
| Oxycodone Hcl/Acetaminophen | 704 | $27K |
| Oxycodone Hcl | 53 | $17K |
| Buprenorphine Hcl | 130 | $12K |
| Buprenorphine Hcl | 17 | $11K |
| Gabapentin | 582 | $9,665 |
| Oxycodone Myristate | 14 | $9,616 |
| Linaclotide | 15 | $8,271 |
| Morphine Sulfate | 276 | $7,245 |
| Naloxone Hcl | 77 | $6,903 |
| Buprenorphine | 15 | $6,059 |
| Tizanidine Hcl | 354 | $4,133 |
| Morphine Sulfate | 117 | $4,081 |
Prescribing Profile
32
Unique Drugs
40.0
Anomaly Score
Patient Profile
67
Avg Age
68%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About